{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:43:31Z","timestamp":1761972211604,"version":"build-2065373602"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00393-012-0983-y","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T12:39:21Z","timestamp":1352378361000},"page":"754-759","source":"Crossref","is-referenced-by-count":6,"title":["Riesenzellarteritis","Giant-cell arteritis"],"prefix":"10.1007","volume":"71","author":[{"given":"M.","family":"Schirmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dejaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.A.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,10]]},"reference":[{"key":"983_CR1","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1136\/ard.2010.149351","volume":"70","author":"Beyer","year":"2011","unstructured":"Beyer C, Axmann R, Sahinbegovic E et al (2011) Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis. Ann Rheum Dis 70(10):1874\u20131875","journal-title":"Ann Rheum Dis"},{"key":"983_CR2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2214\/ajr.184.1.01840283","volume":"184","author":"Bley","year":"2005","unstructured":"Bley TA, Wieben O, Uhl M et al (2005) High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol 184:283\u2013287","journal-title":"AJR Am J Roentgenol"},{"key":"983_CR3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/BOR.0b013e32831cec7b","volume":"21","author":"Blockmans","year":"2009","unstructured":"Blockmans D, Bley T, Schmidt W (2009) Imaging for large-vessel vasculitis. Curr Opin Rheumatol 21:19\u201328","journal-title":"Curr Opin Rheumatol"},{"key":"983_CR4","doi-asserted-by":"crossref","unstructured":"Dasgupta B, Borg FA, Hassan N et al (2010) BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatol (Oxford) 49:1594\u20131597","DOI":"10.1093\/rheumatology\/keq039a"},{"key":"983_CR5","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-0037-1618020","volume":"4","author":"Dejaco","year":"2010","unstructured":"Dejaco C, Wagner AD (2010) Die Pathogenese der Gro\u00dfgef\u00e4\u00dfvaskulitiden. Arthritis Rheuma 4:193\u2013198","journal-title":"Arthritis Rheuma"},{"key":"983_CR6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/WNO.0b013e31820c4421","volume":"31","author":"Hegg","year":"2011","unstructured":"Hegg R, Lee AG, Tagg NT, Zimmerman MB (2011) Statin or nonsteroidal anti-inflammatory drug use is associated with lower erythrocyte sedimentation rate in patients with giant cell arteritis. J Neuroophthalmol 31(2):135\u2013138","journal-title":"J Neuroophthalmol"},{"key":"983_CR7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-146-9-200705010-00004","volume":"146","author":"Hoffman","year":"2007","unstructured":"Hoffman GS, Cid MC, Rendt-Zagar KE et al (2007) Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis. Ann Intern Med 146:621\u2013630","journal-title":"Ann Intern Med"},{"key":"983_CR8","first-page":"70","volume":"30","author":"Loock","year":"2012","unstructured":"Loock J, Henes J, K\u00f6tter I et al (2012) Treatment of refractory giant cell arteritis with cyclophosphamide: a retrospective analysis of 35 patients from three centres. Clin Exp Rheumatol 30(1 Suppl 70):70\u201376","journal-title":"Clin Exp Rheumatol"},{"key":"983_CR9","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/art.22754","volume":"56","author":"Mahr","year":"2007","unstructured":"Mahr AD, Jover JA, Spiera RF et al (2007) Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthr Rheum 56:2789\u20132797","journal-title":"Arthr Rheum"},{"key":"983_CR10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.20030850","volume":"199","author":"Ma-Krupa","year":"2004","unstructured":"Ma-Krupa W, Jeon MS, Spoerl S et al (2004) Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med 199:173\u2013183","journal-title":"J Exp Med"},{"key":"983_CR11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/ard.2007.082115","volume":"67","author":"Mart\u00ednez-Taboada","year":"2008","unstructured":"Mart\u00ednez-Taboada VM, Rodr\u00edguez-Valverde V et al (2008) A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects. Ann Rheum Dis 67(5):625\u2013630","journal-title":"Ann Rheum Dis"},{"key":"983_CR12","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1002\/art.22163","volume":"54","author":"Mazlumzadeh","year":"2006","unstructured":"Mazlumzadeh M, Hunder GG, Easley KA et al (2006) Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial. Arthritis Rheum 54:3310\u20133318","journal-title":"Arthritis Rheum"},{"key":"983_CR13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2008.088351","volume":"68","author":"Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC et al (2009) EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 68:318\u2013323","journal-title":"Ann Rheum Dis"},{"key":"983_CR14","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.20171","volume":"50","author":"Nesher","year":"2004","unstructured":"Nesher G, Berkun Y, Mates M et al (2004) Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 50:1332\u20131337","journal-title":"Arthritis Rheum"},{"key":"983_CR15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/art.11388","volume":"49","author":"Proven","year":"2003","unstructured":"Proven A, Gabriel SE, Orces C et al (2003) Glucocorticoid therapy in giant cell arteritis: duration and treatment outcomes. Arthritis Rheum 49:703\u2013708","journal-title":"Arthritis Rheum"},{"key":"983_CR16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","volume":"372","author":"Salvarani","year":"2008","unstructured":"Salvarani C, Cantini F, Hunder GG (2008) Polymyalgia rheumatica and giant-cell arteritis. Lancet 372:234\u2013245","journal-title":"Lancet"},{"key":"983_CR17","doi-asserted-by":"crossref","unstructured":"Salvarani C, Magnani L, Catanoso M et al (2012) Tocilizumab: a novel therapy for patients with large-vessel vasculitis. Rheumatology (Oxford) 51(1):151\u2013156","DOI":"10.1093\/rheumatology\/ker296"},{"key":"983_CR18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.berh.2005.01.006","volume":"19","author":"Schmidt","year":"2005","unstructured":"Schmidt WA, Gromnica-Ihle E (2005) What is the best approach to diagnose large-vessel vasculitis? Best Pract Res Clin Rheumatol 19:223\u2013242","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"983_CR19","unstructured":"Schmidt WA, Gromnica-Ihle E (2011) Polymyalgia rheumatica und Riesenzellarteriitis (Arteriitis temporalis). In: Busse O, Fleig WE, Mayet WJ et al (Hrsg) Rationelle Diagnostik und Therapie in der Inneren Medizin: Leitlinien-basierte Empfehlungen f\u00fcr die Praxis. Elsevier Deutschland, M\u00fcnchen"},{"key":"983_CR20","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199711063371902","volume":"337","author":"Schmidt","year":"1997","unstructured":"Schmidt WA, Kraft HE, Vorpahl K et al (1997) Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 337:1336\u20131342","journal-title":"N Engl J Med"},{"key":"983_CR21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/rheumatology\/kem322","volume":"47","author":"Schmidt","year":"2008","unstructured":"Schmidt WA, Seifert A, Gromnica-Ihle E et al (2008) Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology 47:96\u2013101","journal-title":"Rheumatology"},{"key":"983_CR22","first-page":"w13156","volume":"141","author":"Seitz","year":"2011","unstructured":"Seitz M, Reichenbach S, Bonel HM et al (2011) Rapid induction of remission in large vessel vasculitis by IL-6 blockade. Swiss Med Wkly 141:w13156","journal-title":"Swiss Med Wkly"},{"key":"983_CR23","first-page":"172","volume":"28","author":"Spies","year":"2010","unstructured":"Spies CM, Burmester GR, Buttgereit F (2010) Methotrexate treatment in large vessel vasculitis and polymyalgia rheumatic. Clin Exp Rheumatol 28(5 Suppl 61):172\u2013177","journal-title":"Clin Exp Rheumatol"},{"key":"983_CR24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0029-1243165","volume":"35","author":"Wagner","year":"2010","unstructured":"Wagner AD, Dejaco C (2010) Emergencies in rheumatology: giant cell arteritis with visual symptoms, vertebrobasilar insufficiency or other ischaemic complications. Aktuel Rheumatol 35:43\u201348","journal-title":"Aktuel Rheumatol"},{"key":"983_CR25","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1172\/JCI117428","volume":"94","author":"Wagner","year":"1994","unstructured":"Wagner AD, Goronzy JJ, Weyand CM (1994) Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease. J Clin Invest 94:1134\u20131140","journal-title":"J Clin Invest"},{"key":"983_CR26","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/1529-0131(199905)42:5<844::AID-ANR2>3.0.CO;2-M","volume":"42","author":"Weyand","year":"1999","unstructured":"Weyand CM, Goronzy JJ (1999) Arterial wall injury in giant cell arteritis. Arthritis Rheum 42:844\u2013853","journal-title":"Arthritis Rheum"},{"key":"983_CR27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-139-6-200309160-00015","volume":"139","author":"Weyand","year":"2003","unstructured":"Weyand CM, Goronzy JJ (2003) Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 139:505\u2013515","journal-title":"Ann Intern Med"},{"key":"983_CR28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMra022694","volume":"349","author":"Weyand","year":"2003","unstructured":"Weyand CM, Goronzy JJ (2003) Medium- and large-vessel vasculitis. N Engl J Med 349:160\u2013169","journal-title":"N Engl J Med"},{"key":"983_CR29","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1172\/JCI118959","volume":"98","author":"Weyand","year":"1996","unstructured":"Weyand CM, Wagner AD, Bjornsson J, Goronzy JJ (1996) Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J Clin Invest 98:1642\u20131649","journal-title":"J Clin Invest"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-012-0983-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-012-0983-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-012-0983-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T11:14:49Z","timestamp":1562325289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-012-0983-y"}},"subtitle":["Update: Diagnose und Therapie","Update: diagnosis and therapy"],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["983"],"URL":"https:\/\/doi.org\/10.1007\/s00393-012-0983-y","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"type":"print","value":"0340-1855"},{"type":"electronic","value":"1435-1250"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}